Skip to main content
Clinical Trials/NCT00860106
NCT00860106
Completed
Phase 4

Study of Predictive Echo Doppler Score and D-dimer Level in Evaluation of the Thromboembolic Event Recurrence After Anticoagulant Treatment Cessation.

University Hospital, Grenoble6 sites in 1 country222 target enrollmentMarch 2005

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Previous Vka Treatment
Sponsor
University Hospital, Grenoble
Enrollment
222
Locations
6
Primary Endpoint
VTE event recurrence
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

The purpose of this trial is to perform a prospective multicentric study to determine predictive ED score and D-dimer level in the evaluation of the thromboembolic event recurrence after anticoagulant treatment cessation.

The patients are included in the study from the anticoagulant treatment cessation. An ED score and a blood sample are performed at this time and one month later. Then, the patients are followed up by phone for 2 years.

Detailed Description

DDimer levels are centralized in University Hospital of Grenoble at the end of the study

Registry
clinicaltrials.gov
Start Date
March 2005
End Date
May 2011
Last Updated
14 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
University Hospital, Grenoble
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • \> 18 and \<80 years old
  • First or second treated proximal VTE event (+/- Pulmonary embolism)
  • Signed informed consent

Exclusion Criteria

  • Active cancer or currently treated
  • Previous VTE\>2
  • Long term anticoagulant treatment for VTE diseases
  • Long term anticoagulant treatment for other diseases
  • Pregnancy, parturient or breast feeding
  • Person deprived of freedom by judicial or administrative decision
  • Consent unsigned

Outcomes

Primary Outcomes

VTE event recurrence

Time Frame: 0-2 years

Study Sites (6)

Loading locations...

Similar Trials